Guaifenesin 400mg Caplets Tablet
NDC Package 77333-360-10
Package Information
Guaifenesin 400mg Caplets (guaifenesin) tablets is a medication used for the temporary relief of coughs caused by the common cold, bronchitis, and other breathing illnesses. This formulation utilizes a tablet delivery system. Marketed by Gendose Pharmaceuticals, Llc, this product is identified by NDC 77333-360 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 359601 - guaiFENesin 400 MG Oral Tablet
- RxCUI: 359601 - guaifenesin 400 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 77333 - Gendose Pharmaceuticals, Llc
- 77333-360 - Guaifenesin 400mg Caplets
- 77333-360-10 - 100 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK (77333-360-25)
- 77333-360 - Guaifenesin 400mg Caplets
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 77333-360-10 identifies a specific commercial package of 100 blister pack in 1 box / 1 tablet in 1 blister pack (77333-360-25) of Guaifenesin 400mg Caplets, a human over the counter drug labeled by Gendose Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gendose Pharmaceuticals, Llc on September 02, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used for the temporary relief of coughs caused by the common cold, bronchitis, and other breathing illnesses. This product is usually not used for ongoing cough from smoking or long-term breathing problems (such as chronic bronchitis, emphysema) unless directed by your doctor. Guaifenesin is an expectorant. It works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier. If you are self-treating with this medication, it is important to read the package instructions carefully before you start using this product to be sure it is right for you. (See also Precautions section.) Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. This product (sustained-release) is not recommended for use in children younger than 12 years unless specifically directed by the doctor. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold. To decrease the risk for side effects, carefully follow all dosage directions. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How is this Gendose Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 77333036010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.